(S)-2-amino-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide

Catalog No. :
ACLHWF709
CAS No. :
253324-50-4
Molecular Formula :
C18H19N3O2
Molecular Weight :
309.37

IUPAC Name:(S)-2-amino-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide

(S)-2-amino-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$905.00Login to see priceInquiryInquiry
250mg97%$2715.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-amino-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide
IUPAC Name(S)-2-amino-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide
MDL No.MFCD26960971
Molecular FormulaC18H19N3O2
Molecular Weight309.37
SMILESC[C@H](N)C(N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C)C1=O)=O
InChI KeyOSDQYEDPZCYWRA-ZBEGNZNMSA-N
SynonymPropanaMide, 2-aMino-N-[(7S)-6,7-dihydro-5-Methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]-,(2S)-;(S)-2-amino-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide;(2S)-2-Amino-N-[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]-Propanamide
CAS No.253324-50-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLHWF709 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLHWF709 route product structure diagram
    ACLHWF709253324-50-4
Inquiry

2. ACLHWF709 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLHWF709 route product structure diagram
    ACLHWF709253324-50-4
Inquiry

Comments (0)